methylprednisolone has been researched along with Chronic Bullous Disease of Childhood in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Da, Z; Li, X; Lu, Z; Su, D | 1 |
| Burns, C; Yetto, T | 1 |
| Ballester, JG; Durán Urdániz, G; Fernández Galar, M; Garcés Bordege, R; Gil Sáenz, FJ; Herrero Varasa, A | 1 |
3 other study(ies) available for methylprednisolone and Chronic Bullous Disease of Childhood
| Article | Year |
|---|---|
LABD-like manifestation in a patient with systemic lupus erythematosus.
Topics: Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Linear IgA Bullous Dermatosis; Lupus Erythematosus, Systemic; Methylprednisolone; Severity of Illness Index; Thalidomide; Young Adult | 2021 |
Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Linear IgA Bullous Dermatosis; Male; Mesalamine; Methotrexate; Methylprednisolone; Middle Aged; Proctitis; Retreatment | 2018 |
[Topical corticosteroids as a therapeutic alternative in linear immunoglobulin A bullous dermatosis in childhood: case report].
Topics: Administration, Topical; Child; Female; Glucocorticoids; Humans; Linear IgA Bullous Dermatosis; Methylprednisolone | 2016 |